ACS Synthetic Biology

Autonomous bioluminescence systems enable continuous light emission in engineered organisms by genetically encoding both luciferase enzymes and their substrate biosynthetic pathways, offering a powerful platform for non-invasive and long-term monitoring of biological processes. However, bioluminescence output is highly sensitive to substrate availability and host metabolic state, often leading to signal instability under energy-limited conditions. Here, we report an alternative luciferin biosynthetic strategy for the bacterial Lux bioluminescence system in which the adenosine triphosphate (ATP)-dependent LuxEC complex is replaced by -dioxygenase (DOX), an enzyme that directly converts fatty acids into fatty aldehydes without consuming ATP. Using machine learning-guided directed evolution, we engineered DOX variants that markedly enhanced bioluminescence intensity when coupled with bacterial luciferase. The resulting ATP-free Lux bioluminescence system enabled single-cell-level bioluminescence imaging and maintained stable light emission under diverse antibiotic treatments, demonstrating enhanced robustness against metabolic perturbations. SIGNIFICANCEAutonomous bioluminescence imaging has become an attractive method for long-term observation of biological phenomena without the need for exogenous substrate addition. However, the light output of existing autonomous bioluminescence systems, including bacterial and fungal pathways, remains ATP-dependent and often declines when cellular metabolism is perturbed, limiting their reliability for quantitative analysis. Here, we report the development of an ATP-independent substrate biosynthesis pathway for the bacterial luciferase system using DOX. To improve system performance, we applied machine learning- guided directed evolution, which significantly enhanced signal intensity and enabled single-cell bioluminescence imaging. Furthermore, the DOX-based bacterial luciferase system maintained stable luminescence under antibiotic treatments, in contrast to the conventional ATP-dependent bacterial luciferase system. In summary, our findings establish a robust ATP-independent autonomous bioluminescence imaging platform that enables monitoring of cellular events under metabolic perturbations.

Genetic systems engineering is constrained by high DNA synthesis costs, assembly inefficiencies, and challenges in expressing complex proteins. To address these limitations, we developed a highly parallel, low-cost pipeline for the design, assembly, and functional screening of genetic systems, which we stress-tested on highly repetitive structural proteins, including spider silk, biocements, reflectins, and talins. The integrated pipeline combines computational genetic systems design, low-cost many-plasmid DNA assembly from oligopools, automated many-to-many mapping using nanopore sequencing data, and a label-free biosensor to measure single-cell protein expression levels. We applied this pipeline to build 240 plasmids, achieving an 88% success rate (up to 2000 bp) using standard clonal isolation and 58% assembly efficiency (up to 5600 bp) without selective DNA purification, while lowering material costs by up to 24-fold. We applied the biosensor to identify genetic factors that create distinct cellular subpopulations with varying protein expression levels. Overall, the integrated pipeline will dramatically lower the cost of high-throughput synthetic biology, while demonstrating how designing genetic systems to improve build efficiency ("design for build") and directly incorporating biosensors into genetic systems ("design for test") will greatly accelerate design-build-test workflows.

High-quality plasmid DNA purification at high throughput remains a significant bottleneck in molecular biology and bioengineering. Current methods frequently fail to deliver sufficient yields of pure, transfection-grade DNA required for genetic engineering applications in mammalian cells. Here, we present a Biofoundry-based automated pipeline using the CyBio FeliX robotic liquid handling platform to rapidly purify plasmid DNA with minimal manual intervention. The protocol leverages Solid Phase Reversible Immobilisation (SPRI)-based magnetic bead technology to ensure consistency, scalability, and DNA purity suitable for downstream viral particle production and mammalian cell transfection. The pipeline supports flexible processing of between 8 and 96 samples per run, making it adaptable across a wide range of experimental scales. The protocol is openly available via Earlham Institute GitHub repository, enabling broad adoption across the bioscientific community and contributing to the growing toolkit of reproducible, scalable engineering biology workflows. In this work, we employed an integrated robotic pipeline to process 528 pooled DNA plasmids and built a Lentiviral DNA plasmid library for lineage tracing, validated the library by sequencing, and demonstrated efficacy in downstream mammalian cell transfection experiments.

Bacterial surface structures have enabled display systems with broad impact across biotechnology, but their narrow host range limits their deployment into diverse species. Conversely, Type IV Pili (TFP) are ubiquitous, structurally conserved appendages found across bacteria, but have been minimally explored for display. Here, we describe a computational framework for predicting viable insertion sites in major pilins for stable TFP-mediated display, which we apply to the major pilin PilA1 of the cyanobacterium Synechocystis sp. PCC 6803 to enable covalent binding to living materials. By analyzing an Alphafold3-generated PilA1 monomer alongside known multimeric TFP multimers, our pipeline identifies non-interfacial, solvent-accessible, and flexible sites for optimal PilA1 display. We probe these sites with both full-length and truncated SpyCatcher003 at two different expression levels. We show that cells expressing these PilA1-SpyCatcher003 fusions maintain up to 8-fold higher levels of cell suspension than previous C-terminal PilA1 display platforms, suggesting improved TFP assembly despite more than a two-fold increase in cargo size. Additionally, we validate SpyCatcher003 reactivity across the engineered strains, enabling covalent attachment of SpyTag003-containing proteins on the Synechocystis surface. Lastly, we utilize this covalent patterning to achieve a four-fold increase in Synechocystis loading into a living material without compromising its viscoelastic or mechanical properties. Taken together, this work provides a predictive framework for TFP engineering, and opens the door towards programmable surface display across the breadth of bacterial species.

Engineered living materials seek to capture the sensitivity, responsiveness, and programmable characteristics of biological systems. One emergent property of living systems is genetically driven spatial patterning, which controls cell differentiation and the development of complex multicellular organisms. Inspired by this capability, we use bacteria to spatially control material assembly. In our system, extracellular electron transfer (EET) flux from Shewanella oneidensis drives hydrogel synthesis via copper-catalyzed radical polymerization. We first construct a recombinant quorum sensing system in S. oneidensis that allows for cell-cell communication between "sender" and "receiver" cells through an autoinducer. We then examine controlled gene expression and EET-driven chemical transformation in various synthetic consortia. Via diffusion through agarose, we examine 2D patterns of gene expression relative to localized sender cell populations and demonstrate controlled hydrogel crosslinking in predictable patterns. Finally, we apply computational methods and NOT logic in "receiver" cells towards more complex patterns of gene expression. Our results highlight the potential of bacteria to program material systems with life-like properties including self-assembly, environmental responsiveness, and patterned differentiation.

Cell-free protein synthesis (CFPS) is a powerful platform for synthetic biology, yet the factors governing reaction longevity remain poorly understood despite their importance for high-throughput applications. Here, the three principal determinants of CFPS performance--DNA template design, reaction composition, and lysate genotype--were systematically optimized to extend reaction lifetime in a 384-well plate format. Different energy regeneration systems were evaluated through real-time pH monitoring and metabolomic analyses to identify the metabolic constraints limiting prolonged protein synthesis. Lysates prepared from engineered Escherichia coli BL21(DE3) strains were further examined to assess the contributions of DNA, RNA, and amino acid stabilization. Systematic optimization of amino acid, nucleoside triphosphate, polyethylene glycol, and lysate concentrations identified DNA template stability and amino acid preservation as the primary factors sustaining CFPS activity. Combining these improvements yielded reactions that remained productive for >14 h and produced 567 {+/-} 64 g mL-1 active deGFP. These findings establish practical strategies for extending CFPS lifetime and improving high-throughput cell-free platforms.

Optogenetic control enables light-actuated regulation of gene expression and provides a programmable interface between living cells and electronic systems. However, routine prototyping of optogenetic constructs remains limited by infrastructure. Existing closed-loop platforms often require chemostats, microfluidics, robotic handling, or custom optical sensors, which can increase cost, reduce accessibility, or constrain measurement performance. Here, we present LEMOS 2.0, an updated LED-Embedded Microplate for Optogenetic Studies, a low-cost device for optogenetic stimulation and gene-circuit characterization inside standard off-the-shelf microplate readers. LEMOS 2.0 builds on the original LEMOS platform by increasing throughput from 16 to 32 microwells and reducing light leakage between adjacent microwells, allowing dark conditions to be used as an additional illumination state. The device consists of a 3D-printed frame, individually addressable LEDs positioned next to each microwell, a rechargeable battery, and an onboard microcontroller for Bluetooth-based wireless communication. Biocompatible polydimethylsiloxane microwells are cast directly into the device by replica molding, allowing bacterial cultures to be stimulated while optical density and fluorescence are measured by the microplate reader. This protocol describes the full LEMOS 2.0 workflow, including device fabrication, circuit assembly, Arduino programming, PDMS microwell casting, plate-reader setup, strain and culture preparation, automated experiment execution, device cleanup, and fluorescence/OD600 data analysis. As a demonstration, the protocol uses the CcaSR optogenetic system, in which sfGFP expression is activated by green light and repressed by red light. LEMOS 2.0 is intended to make optogenetic perturbation and gene-expression characterization more accessible to wet-lab users, enabling faster design-build-test-learn cycles without requiring specialized bioreactor or microfluidic infrastructure.

Tandem Interspaced Guide RNA (TIGR)-TIGR-associated (Tas) systems are a newly discovered family of ultracompact, modular RNA-guided DNA-targeting proteins that function without a protospacer adjacent motif (PAM) requirement. Their utility as genome engineering tools in microbes remains unexplored. Here, we report the first functional implementation of TIGR-Tas in Saccharomyces cerevisiae for genome engineering. We show that TasR from Parcubacteria (ParTasR) can be programmed by user-defined tigRNAs to generate targeted DNA double-strand breaks at yeast endogenous loci. By co-delivering ParTasR with customized tigRNAs and donor templates, we achieved precise gene fragment deletion and targeted codon substitutions at multiple genomic loci. The multiplex genome engineering capability of this TIGR-Tas system was demonstrated through high-efficiency multiplex gene disruption and chromosomal assembly of a lycopene biosynthesis pathway while inactivating an endogenous gene. This work establishes TIGR-Tas as a valuable addition to the yeast genome engineering toolbox, particularly for applications requiring PAM-independent targeting or compact delivery.

Fluorescent proteins are fundamental tools for cellular imaging. Most fluorescent proteins in routine use, including GFP, are derived from the jellyfish Aequorea victoria and emit blue-green light, which is strongly absorbed and scattered by tissue, limiting imaging depth. Far-red and near-infrared fluorescent proteins, engineered from bacteriophytochromes, address this limitation because far-red light penetrates tissue considerably further. However, these proteins are typically much dimmer than their A. victoria -derived counterparts. Improving brightness by conventional directed evolution requires screening large random mutant libraries, a process that is slow, labor-intensive, and often impractical outside specialized laboratories. We utilized an active-learning-guided directed evolution workflow that identified improved variants from substantially less data than conventional screening. Each round coupled automated, miniaturized cell-free protein expression directly from a DNA template without cloning or cell culture, with a machine-learning model retrained on cumulative sequence-function data to nominate the most informative variants for the next round. Applied to miRFP670nano3, this workflow screened 120 variants across successive rounds and identified twelve with improved brightness, the best four-fold brighter in bacterial systems. However, these gains did not translate when the variants were evaluated in mammalian cells, indicating that performance can be strongly dependent on cellular context. Retrospective simulation across benchmark datasets from ProteinGym showed that performing more experimental batches with fewer samples per batch consistently accelerated convergence to high-fitness sequences. Incorporating protein-language-model derived zero-shot fitness priors also accelerated convergence, but only in proportion to how well each prior score correlated with the true fitness landscape. Together, these findings established generalizable design rules, favoring smaller acquisition batches and confidence-weighted priors, for engineering proteins from minimal experimental data. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=55 SRC="FIGDIR/small/744534v1_ufig1.gif" ALT="Figure 1"> View larger version (11K): org.highwire.dtl.DTLVardef@14992f7org.highwire.dtl.DTLVardef@14fad5borg.highwire.dtl.DTLVardef@1fe4ec2org.highwire.dtl.DTLVardef@e4b1f0_HPS_FORMAT_FIGEXP M_FIG C_FIG

The Modular Cloning (MoClo) and PhytoBrick standards have revolutionized plant synthetic biology by establishing a standardized, hierarchical assembly grammar. However, as the engineering of complex metabolic pathways, multi-trait stacks, and synthetic gene circuits expands, existing toolkits hit practical boundaries in assembly capacity and fixed grammars. To overcome these bottlenecks, we present MozClo, an expansion of the MoClo/PhytoBrick architecture. MozClo expands the standard Level 1 assembly framework to 10 positions using new L1 acceptors, end-linkers and dummy parts. We also identify and resolve a critical, sticky-end collision at L1 position 7 that has caused assembly failures during L2 cloning of large plasmids. To address commercial DNA synthesis length constraints and to lower cloning costs, we designed a universal 5-in-1 gene fragment multiplexing system. This architecture embeds up to five distinct parts flanked by orthogonal pairs of BpiI restriction sites into a single synthesized fragment, allowing them to sort independently into their respective L0 acceptor plasmids while maintaining complete modular flexibility of part types. Finally, we provide Level 2 cloning backbones with built in selection genes for common soybean transformation methods to facilitate downstream plant selection. Together, these advancements reduce DNA synthesis overhead and accelerate the construction of complex multigene payloads for plant biotechnology.

Rising demand for rare earth elements, including lanthanides (Lns), has intensified environmental pressures and supply-chain vulnerabilities, motivating the development of bio-based methods for their extraction and separation. However, the lack of high-throughput assays for analysing the selectivity of lanthanide-binding proteins remains a key bottleneck in engineering bio-based Ln-extraction systems. Here, we report the development of high-throughput assays based on Ln-responsive protein biosensors. These {beta}-lactamase-based biosensors contain receptors with a single Ln-binding site derived from either lanmodulin or the AI-designed protein RF2. We established multiplexed colourimetric assays that quantify biosensor activity and selectivity in vitro and in the periplasm of E. coli. We further demonstrate that E. coli cells expressing these biosensors exhibit Ln-dependent survival in the presence of {beta}-lactam antibiotics. These platforms enable large-scale testing of Ln biosensors and Ln-binding proteins.

Building high-performance microbial cell factories requires dynamic coordination of resource allocation among cellular growth, target-product biosynthesis, and endogenous host metabolism. However, existing polyploid engineering strategies rely primarily on static manipulation of chromosome copy number. Although increasing gene dosage can enhance biosynthetic capacity, static designs cannot readily accommodate the changing metabolic demands encountered during fermentation. Here, we developed a metabolite-responsive dynamic polyploid engineering strategy that couples chromosome ploidy to the cellular metabolic state. We first constructed a high-performance L-threonine biosensor and used it to sense intracellular L-threonine levels and regulate ftsZ expression, a key cell-division gene, thereby establishing a dynamic polyploid system that requires neither exogenous inducers nor antibiotics. This system enabled engineered cells to progressively transition from polyploid to haploid during fermentation, accompanied by stage-specific remodeling of cellular physiology and metabolism. Physiological characterization revealed a marked increase in cell size and alterations in cell-envelope properties during the polyploid phase, followed by a gradual decrease in chromosome copy number as fermentation progressed. Transcriptomic and metabolomic analyses further demonstrated that dynamic ploidy transitions induced global metabolic network rewiring, remodeling the tricarboxylic acid cycle and amino acid metabolism while redirecting carbon flux toward the biosynthesis of aspartate-family amino acids. Ultimately, dynamic polyploid engineering substantially enhanced L-threonine production, enabling the engineered strain to achieve an L-threonine titer of 183.1 g/L and a yield of 0.67 g/g glucose in 5-L fed-batch fermentation without antibiotics or exogenous inducers. These findings show that dynamic regulation of chromosome ploidy can couple gene-dosage control with remodeling of cellular physiology and metabolic networks, providing a new engineering strategy to overcome the limitations of static polyploid designs and build high-performance microbial cell factories.

Efficient conversion of polymeric feedstocks for sustainable bioprocessing requires robust strategies for enzyme assembly and cell-surface attachment. In nature, cellulosomes achieve highly efficient lignocellulosic polysaccharide deconstruction through scaffoldin-mediated organization of carbohydrate-active enzymes via specific cohesin-dockerin interactions. These modular binding pairs are therefore attractive tools for synthetic biology and engineered whole-cell biocatalysis, yet their performance has been studied mainly in vitro or in yeast or Gram-positive bacteria. The factors governing their function on the microbial surfaces - particularly those of Gram-negative bacteria - remain incompletely understood. Here, we investigated the binding efficiency and interaction stability of two thermophilic cohesin-dockerin pairs from Acetivibrio thermocellus and Acetivibrio clariflavus displayed on the surface of the genome-streamlined strain Pseudomonas putida EM371 using an Ag43-based display system from Escherichia coli and a dockerin-tagged fluorescent reporter. We show that binding efficiency is strongly affected by the temperature at which the cohesin-dockerin complex is formed. We further demonstrate that the interaction stability of the A. clariflavus pair can be substantially improved by targeted amino acid substitutions in the dockerin domain guided by molecular dynamics simulations and free-energy calculations. These results identify key parameters controlling the performance of thermophilic cohesin-dockerin modules on living bacterial cell surfaces and establish a computation-guided strategy for engineering more stable cellulosome-derived assembly interfaces, advancing the development of modular whole-cell platforms for sustainable biotechnology applications. TOC graphics O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/743725v1_ufig1.gif" ALT="Figure 1"> View larger version (65K): org.highwire.dtl.DTLVardef@18a97b6org.highwire.dtl.DTLVardef@1ee3ff4org.highwire.dtl.DTLVardef@a8dd60org.highwire.dtl.DTLVardef@5dd332_HPS_FORMAT_FIGEXP M_FIG C_FIG Cohesin-dockerin pairs provide strong and modular non-covalent interactions for synthetic biology and biotechnology applications. We establish an experimental and computational pipeline to improve their two key properties - binding efficiency and interaction stability - on the surface of Pseudomonas putida, enabling more robust cell-surface assembly systems.

Multidrug-resistant pathogens pose a major threat to One Health. Within the past decade, CRISPR-Cas systems have been explored as sequence-specific antimicrobials. While chromosomal injury has been considered the primary mechanism underlying pathogen killing by CRISPR-Cas antimicrobials, the synergistic role of gene disruption together with chromosomal injuries remains poorly understood. In this study, we characterized a new class of CRISPR-Cas antimicrobials that simultaneously cotarget essential and defensive genes to enhance potency against the clinically relevant pathogen Staphylococcus aureus. High-throughput CRISPR screening identified top-performing guide RNAs for twenty functionally diverse essential and defensive genes across the S. aureus genome. CRISPR-Cas antimicrobials were modularly formulated to target single or multiple gene loci and packaged in phage-like particles for specific delivery. By engineering an S. aureus production host with a chromosomally integrated anti-CRISPR protein, we demonstrated efficient production of CRISPR-Cas antimicrobials targeting any S. aureus chromosomal locus without self-targeting. Characterization of CRISPR-Cas antimicrobials with single guide RNA designs revealed that potency varied according to targeted gene function, achieving up to a 4-log10 reduction in viability and outperforming traditional antibiotics. Multiplexed configurations were consistently more effective than single-targeting designs, with the top-performing design demonstrating a 4.7-log10 reduction in viability. Cotargeting essential and defensive genes revealed synergies that led to improved lethality and attenuated resistance, with enhanced activity in biofilms compared to traditional antibiotics. Genes involved in signaling and stress responses were important defensive targets for developing cotargeting CRISPR-Cas antimicrobials. Overall, this study establishes design principles for synergistic CRISPR-Cas antimicrobials applicable to next-generation precision antimicrobial development. SIGNIFICANCEThe ability to effectively combat multidrug-resistant pathogens is of primary importance to One Health. This study develops a generalizable design principle for formulating potent CRISPR-Cas antimicrobials that exploit synergistic cotargeting strategies for enhanced pathogen killing. In addition to chromosomal injuries, we found that disruption of gene function plays a crucial role in determining the lethality of CRISPR-Cas antimicrobials, providing a generalizable framework for effective CRISPR-Cas antimicrobial design. The development of a CRISPR-Cas antimicrobial production host with stable, chromosomally integrated anti-CRISPR genes greatly expands the modularity, adaptability, and efficiency of formulating CRISPR-Cas antimicrobials and enables deeper insights into the molecular mechanisms involved in eliminating multidrug-resistant pathogens.

The basidiomycete Ustilago maydis is a well-characterized model organism for studying pathogen-host interactions and of great interest for a broad spectrum of biotechnological applications. We set here to develop light inducible molecular tools to enable dynamic studies on signaling networks and fungi-host communication, and for metabolic engineering approaches. In particular, light-controlled, optogenetic switches provide quantitative, spatio-temporal control capabilities, are minimal invasive and reversible. We engineered two blue light-inducible LOV-domain-based gene expression switches, to up- (Blue-ON) and down-regulate (Blue-OFF) gene expression, and performed a functional characterization in sporidia and hyphae of U. maydis. Profiting from the dynamic control ranges and rapid kinetics, we implemented the optoswitches to control cell morphology by initiating the transition from a haploid sporidial cellular morphotype to filaments upon regulation of the levels of the polarity factor Rac1 and its constitutive active mutant Q61L. In addition to showing how expression level of effectors can be precisely regulated as an approach to understand fungi-plants interaction, we show in two proof-of-principle applications targeted control over U. maydis filamentous fungal invasion of plant tissue and the mechanisms of tumor formation. For this we placed under Blue-ON and Blue-OFF control two U. maydis effectors, See1 (Seedling efficient effector 1) and TIN2 (Tumor inducing 2), and tumor formation was assayed on maize leaves. Taken together, this study established blue-light switches as effective tools to control morphogenesis and pathogenesis in U. maydis.

Orthogonal gene expression systems based on bacteriophage-derived T7 RNA polymerase (T7 RNAP) offer a promising strategy for decoupling engineered transcription from host regulatory networks. Although recent advances have enabled productive T7 RNAP-mediated expression in Saccharomyces cerevisiae, strategies for independently controlling multiple genes within a shared T7 transcriptional framework remain limited. Here, we developed a modular pYTK-compatible T7 RNAP expression architecture that separates overall transcriptional capacity from gene-specific control of protein output. We established interchangeable T7 promoter, terminator, polyadenylation signal, and 5 untranslated region (UTR) parts for combinatorial assembly. Analysis of expression cassette dosage showed that transcript abundance and expression output scale with cassette copy number, with high-copy constructs producing transcript levels comparable to those driven by the GAL1 promoter. To enable gene-specific tuning, we constructed a library of fourteen 18 nt UTR elements that generated a [~]38-fold range of protein output from a common T7 promoter. Application of this library to a three-gene {beta}-carotene biosynthesis pathway enabled [~]20-fold variation in product titer through UTR assignment alone, without altering promoter identity or gene copy number. Together, these results establish a modular T7 RNAP expression framework in which cassette dosage defines overall transcriptional capacity while interchangeable UTR elements enable gene-specific tuning of expression output, providing a practical strategy for multigene expression control in yeast.

Recombinant proteins have transformative potential in biomedicine, but their production is often costly and carries contamination risks. Plants offer an attractive alternative, with low growth costs and reduced pathogen risk, yet their slow growth cycles limit their use for rapid protein engineering. Here, we establish Marchantia polymorpha, a genetically tractable liverwort with a short life cycle, as a new platform for recombinant protein production. Using stable Agrobacterium-mediated transformation, we expressed an anti-mCherry nanobody fused to the fluorescent protein mTurquoise2 with different purification tags. Expression levels reached up to [~]120 {micro}g/g fresh weight, and nanobody functionality was validated through a microscopy-based bead-binding assay. This yield rivals that of established systems such as Nicotiana benthamiana. Our results position M. polymorpha as a scalable, safe, and efficient chassis for protein engineering, with broad potential for applications in synthetic biology. This work opens the door to exploiting liverwort biotechnology for fast, cost-effective, and biosafe production of valuable recombinant proteins. Graphical Table of Contents O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=133 SRC="FIGDIR/small/733889v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@aabc4aorg.highwire.dtl.DTLVardef@12f9fa4org.highwire.dtl.DTLVardef@199d3e0org.highwire.dtl.DTLVardef@2533a4_HPS_FORMAT_FIGEXP M_FIG C_FIG

BackgroundThe corn smut fungus Ustilago maydis is an important microbial model organism representing a genetically amenable and readily cultivable basidiomycete. Research in this fungus addresses a broad range of fundamental questions and its biotechnological exploitation is on the rise. Although genetic engineering in principle is well established, efficient methodology for synthetic biology approaches such as metabolic engineering or pathway transplantation has remained limited. ResultsHere, we present a comprehensive toolbox for U. maydis based on modular cloning and the characterization of more than 20 promoters. Careful comparative evaluation of insertion loci and terminator as well as reporter effects was conducted and a novel color-based strategy for straightforward genome integration was implemented. Moreover, the cloning and subsequent one-step integration of four transcriptional units into U. maydis was demonstrated by creating a "rainbow" strain producing four fluorescent proteins. ConclusionOverall, this next generation toolkit strongly advances genetic engineering and systems biology approaches in U. maydis, fostering its development into a valuable and competitive fungal chassis and prime model, particularly in applied research.

Nicotine accumulates in the gut and drives non-alcoholic steatohepatitis (NASH) via the gut-liver axis, yet no effective clinical intervention is currently available. To address this challenge, the probiotic Escherichia coli Nissle 1917 (EcN) was engineered for in situ nicotine clearance in the gut. Mutational screening of nicotine oxidoreductase 2 (PpNicA2) identified a highly active variant, PpNicA2A107R. Its incorporation into EcN together with an electron transfer protein (CycN) and a newly identified transporter (T3/T7) yielded 80% nicotine-degrading activity. Chromosomal integration of this module generated a stable strain, EcN-N12, which in NASH mouse models depleted intestinal nicotine, rescued hepatic lipid metabolism, alleviated tissue damage, and intercepted the nicotine-mediated gut-liver axis pathological progression. This work thus offers an effective and clinically translatable approach for nicotine-associated diseases.

DNA assembly is a cornerstone of synthetic biology, enabling the construction of bespoke genetic systems for applications ranging from metabolic engineering to DNA nanotechnology. Conventional Gibson Assembly (GA), the most widely used method, relies on 5' exonucleolytic resection and elevated temperatures ([~]50 {degrees}C), which together prevent the retention of 5' modifications and restrict compatibility with temperature-sensitive functionalities. Here, we report a DNA assembly strategy, 3 exonuclease-mediated low-temperature DNA assembly (3LTDA), which generates complementary 5' overhangs while preserving 5' end integrity. This approach enables the efficient assembly of blunt-ended, 5'-functionalised DNA fragments into both linear and circular constructs at ambient temperature (21 {degrees}C), with some assembly observed at temperatures as low as 4{degrees}C. We systematically optimise reaction conditions and demonstrate that this method supports efficient plasmid re-circularisation and multi-fragment assembly, including the construction of a [~]12.5 kbp plasmid from multiple DNA components. Comparative analysis across several DNA substrates shows that, under their respective optimal conditions, this approach matches or exceeds GA performance, improving assembly efficiency by up to 12.8%. Sequence analysis confirms high fidelity with no detectable base-pairing errors across assembled junctions. Crucially, this method preserves chemically functionalised 5' termini, enabling downstream conjugation and biochemical functionality. Retention of azide and biotin modifications was verified through fluorescence imaging, bead-based co-localisation, and enzymatic activity in ELISA-based assays. This is in contrast to GA-assembled controls, which showed complete loss of functionality under comparable conditions. We further assembled 5 kbp dsDNA using 3LTDA from four independent segments, three with different fluorescence reporters, and the fourth containing a biotin group for microparticle conjugation, each on the 5 end. Under fluorescence illumination, bead-bound DNA with all three fluorescence markers were detected. Conventional GA assembled constructs, on the other hand, failed to retain the reporter groups and the fluorescent images did not show the presence of any fluorescent markers. In addition to enhanced performance, the method could also reduce reagent cost and eliminate the need for elevated temperatures, simplifying workflows and expanding the applicability of multi-functionalised DNA constructs. Collectively, this work establishes 3LTDA as a robust, low-temperature alternative to conventional GA, with advantages for applications requiring precise chemical modification, temperature-sensitive components, or deployment outside conventional laboratory environments.